These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23951373)

  • 21. Japanese encephalitis vaccine: need of the hour in endemic states of India.
    Verma R
    Hum Vaccin Immunother; 2012 Apr; 8(4):491-3. PubMed ID: 22370517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology and risk factors of Japanese encephalitis in Taiwan, 2010-2022.
    Hsu JY; Hung CC; Tsou TP; Chen WC
    PLoS Negl Trop Dis; 2023 Oct; 17(10):e0011421. PubMed ID: 37782654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coverage of Japanese encephalitis routine vaccination among children in central India.
    Tandale BV; Deshmukh PS; Narang R; Qazi MS; Padmaja GV; Deshmukh PR; Raut AV; Narlawar UW; Jha PK; Rajderkar SS;
    J Med Virol; 2023 Jan; 95(1):e28155. PubMed ID: 36114690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonlinear and Threshold Effect of Meteorological Factors on Japanese Encephalitis Transmission in Southwestern China.
    Liu Z; Zhang Y; Tong MX; Zhang Y; Xiang J; Gao Q; Wang S; Sun S; Jiang B; Bi P
    Am J Trop Med Hyg; 2020 Dec; 103(6):2442-2449. PubMed ID: 33124540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of a single dose of Japanese encephalitis vaccine among adults, Assam, India, 2012-2018.
    Khan SA; Choudhury P; Kakati S; Doley R; Barman MP; Murhekar MV; Kaur H
    Vaccine; 2021 Aug; 39(35):4973-4978. PubMed ID: 34325931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epidemiological characteristics and related influencing factors on Japanese encephalitis in Hainan Province].
    Pan XH; Sun LY; Wang CL; Zhu J; Fu ZW; Zeng ZC; Zeng XX; Yan XJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 May; 30(5):471-4. PubMed ID: 19799143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.
    Kim DS; Houillon G; Jang GC; Cha SH; Choi SH; Lee J; Kim HM; Kim JH; Kang JH; Kim JH; Kim KH; Kim HS; Bang J; Naimi Z; Bosch-Castells V; Boaz M; Bouckenooghe A
    Hum Vaccin Immunother; 2014; 10(9):2656-63. PubMed ID: 25483480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Japanese Encephalitis Surveillance and Immunization - Asia and Western Pacific Regions, 2016.
    Heffelfinger JD; Li X; Batmunkh N; Grabovac V; Diorditsa S; Liyanage JB; Pattamadilok S; Bahl S; Vannice KS; Hyde TB; Chu SY; Fox KK; Hills SL; Marfin AA
    MMWR Morb Mortal Wkly Rep; 2017 Jun; 66(22):579-583. PubMed ID: 28594790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization.
    Kosalaraksa P; Watanaveeradej V; Pancharoen C; Capeding MR; Feroldi E; Bouckenooghe A
    Pediatr Infect Dis J; 2017 Apr; 36(4):e108-e113. PubMed ID: 28030526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and Safety of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Vaccine Given 1 Year After Primary Immunization in Healthy Children in the Republic of Korea.
    Kim DS; Jang GC; Cha SH; Choi SH; Kim HM; Kim JH; Kang JH; Kim JH; Kim KH; Bang J; Naimi Z; Bouckenooghe A; Bosch-Castells V; Houillon G
    Pediatr Infect Dis J; 2016 Feb; 35(2):e60-4. PubMed ID: 26535878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of the Viet Nam produced, mouse brain-derived, inactivated Japanese encephalitis vaccine in Northern Viet Nam.
    Marks F; Nguyen TT; Tran ND; Nguyen MH; Vu HH; Meyer CG; You YA; Konings F; Liu W; Wierzba TF; Xu ZY
    PLoS Negl Trop Dis; 2012; 6(12):e1952. PubMed ID: 23272262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High vaccination coverage, inadequate knowledge and high vector density: Findings from a community-based cross-sectional study on Japanese Encephalitis in Yangon, Myanmar.
    Kyaw PP; Shewade HD; Kyaw NTT; Hnin Phyo K; Lin HH; Kyaw AMM; Mya MM; Thaung S; Maung Maung YN
    F1000Res; 2020; 9():6. PubMed ID: 33014343
    [No Abstract]   [Full Text] [Related]  

  • 33. Japanese encephalitis surveillance and immunization--Asia and the Western Pacific, 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(33):658-62. PubMed ID: 23965828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety.
    Feroldi E; Pancharoen C; Kosalaraksa P; Chokephaibulkit K; Boaz M; Meric C; Hutagalung Y; Bouckenooghe A
    Pediatr Infect Dis J; 2014 Jun; 33(6):643-9. PubMed ID: 24717964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.
    Paulke-Korinek M; Kollaritsch H; Kundi M; Zwazl I; Seidl-Friedrich C; Jelinek T
    Vaccine; 2015 Jul; 33(30):3600-4. PubMed ID: 26036947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine.
    Yun KW; Lee HJ; Park JY; Cho HK; Kim YJ; Kim KH; Kim NH; Hong YJ; Kim DH; Kim HM; Cha SH
    Vaccine; 2018 Mar; 36(11):1398-1404. PubMed ID: 29429815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High vaccination coverage and inadequate knowledge: Findings from a community-based cross-sectional study on Japanese Encephalitis in Yangon, Myanmar.
    Kyaw PP; Shewade HD; Kyaw NTT; Hnin Phyo K; Lin HH; Kyaw AMM; Mya MM; Thaung S; Maung Maung YN
    F1000Res; 2020; 9():6. PubMed ID: 33014342
    [No Abstract]   [Full Text] [Related]  

  • 38. A model immunization programme to control Japanese encephalitis in Viet Nam.
    Yen NT; Liu W; Hanh HD; Chang NY; Duong TN; Gibbons RV; Marks F; Thu NA; Hong NM; Park JK; Tuan PA; Nisalak A; Clemens JD; Xu ZY
    J Health Popul Nutr; 2015 Mar; 33(1):207-13. PubMed ID: 25995736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Japanese encephalitis disease burden and clinical features of Japanese encephalitis in four cities in the People's Republic of China.
    Yin Z; Wang H; Yang J; Luo H; Li Y; Hadler SC; Sandhu HS; Fischer M; Jiang Y; Zhang Z; Liu G; Li L; Johnson BW; Liang X;
    Am J Trop Med Hyg; 2010 Oct; 83(4):766-73. PubMed ID: 20889863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies.
    Ginsburg AS; Meghani A; Halstead SB; Yaich M
    Hum Vaccin Immunother; 2017 Oct; 13(10):2222-2231. PubMed ID: 28841362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.